Efficacy of Osimertinib in Afatinib-resistant Lung Cancer Harboring Uncommon EGFR Mutations: Case Report and Literature Review

Yuanyuan Zhao, Linzhu Zhai, Lei Deng, Balazs Halmos, Haiying Cheng

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)e466-e469
JournalClinical lung cancer
Issue number3
StatePublished - May 2021


  • Compound mutations
  • Epithelial growth factor receptor
  • Non–small-cell lung cancer
  • Osimertinib
  • Uncommon mutations

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Cancer Research

Cite this